Related Experiment Video
Updated: Jun 26, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among
Kui Deng1, Xiong-Fei Pan1,2, Markus W Voehler3
1Vanderbilt Epidemiology Center and Division of Epidemiology Department of Medicine Vanderbilt University Medical Center Nashville TN USA.
New lipoprotein biomarkers, such as apolipoprotein B/A1 ratio, show stronger associations with coronary heart disease (CHD) risk than standard lipids. These findings may improve CHD risk prediction in diverse populations.
Area of Science:
- Cardiovascular disease research
- Lipidomics and metabolomics
- Population health studies
Background:
- Association between comprehensive lipoprotein profiles and incident coronary heart disease (CHD) is understudied in diverse populations.
- Standard lipid panels may not fully capture CHD risk across different racial and geographical groups.
Purpose of the Study:
- To investigate the association between detailed lipoprotein profiles and incident CHD in racially diverse populations.
- To compare the predictive power of novel lipoprotein biomarkers against conventional lipid measurements for CHD risk.
Main Methods:
- Nested case-control studies involving 3438 individuals across White American, Black American, and Chinese adult populations.
- Analysis of 36 plasma lipids, lipoproteins, and apolipoproteins using nuclear magnetic resonance spectroscopy.
- Logistic regression models adjusted for confounders to assess associations with incident CHD.
Main Results:
- Conventional lipids (total cholesterol, triglycerides, LDL-C, HDL-C) were associated with incident CHD.
- Seventeen lipoprotein biomarkers demonstrated stronger associations with CHD risk than conventional lipids.
- Key biomarkers include apolipoprotein B/A1 ratio (OR, 1.57), LDL-triglycerides (OR, 1.55), and apolipoprotein B (OR, 1.49), with consistent findings across demographic and lifestyle subgroups.
Conclusions:
- Specific lipoprotein biomarkers, including apolipoprotein B/A1 ratio, apolipoprotein B, and LDL-triglycerides, are strongly and consistently linked to incident CHD.
- Comprehensive lipoprotein profiling may enhance CHD risk assessment beyond standard lipid panels.
- Findings support the utility of advanced lipid measures for diverse populations.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

